FR2791142B1 - Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa - Google Patents

Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa

Info

Publication number
FR2791142B1
FR2791142B1 FR9903304A FR9903304A FR2791142B1 FR 2791142 B1 FR2791142 B1 FR 2791142B1 FR 9903304 A FR9903304 A FR 9903304A FR 9903304 A FR9903304 A FR 9903304A FR 2791142 B1 FR2791142 B1 FR 2791142B1
Authority
FR
France
Prior art keywords
brefeldine
cpas
presentation
increase
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9903304A
Other languages
English (en)
Other versions
FR2791142A1 (fr
Inventor
Emmanuel Drouet
Cecile Verniol
Christian Drouet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Joseph Fourier Grenoble 1
Original Assignee
Universite Joseph Fourier Grenoble 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Joseph Fourier Grenoble 1 filed Critical Universite Joseph Fourier Grenoble 1
Priority to FR9903304A priority Critical patent/FR2791142B1/fr
Priority to AU32988/00A priority patent/AU3298800A/en
Priority to EP00910959A priority patent/EP1163516A1/fr
Priority to PCT/FR2000/000636 priority patent/WO2000055622A1/fr
Publication of FR2791142A1 publication Critical patent/FR2791142A1/fr
Application granted granted Critical
Publication of FR2791142B1 publication Critical patent/FR2791142B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16211Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16211Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
FR9903304A 1999-03-17 1999-03-17 Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa Expired - Fee Related FR2791142B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR9903304A FR2791142B1 (fr) 1999-03-17 1999-03-17 Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa
AU32988/00A AU3298800A (en) 1999-03-17 2000-03-16 Effect of brefeldin a on antigen-presenting cells
EP00910959A EP1163516A1 (fr) 1999-03-17 2000-03-16 Effet de la brefeldine a sur les cellules presentatrices d'antigenes
PCT/FR2000/000636 WO2000055622A1 (fr) 1999-03-17 2000-03-16 Effet de la brefeldine a sur les cellules presentatrices d'antigenes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903304A FR2791142B1 (fr) 1999-03-17 1999-03-17 Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa

Publications (2)

Publication Number Publication Date
FR2791142A1 FR2791142A1 (fr) 2000-09-22
FR2791142B1 true FR2791142B1 (fr) 2001-06-22

Family

ID=9543309

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9903304A Expired - Fee Related FR2791142B1 (fr) 1999-03-17 1999-03-17 Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa

Country Status (4)

Country Link
EP (1) EP1163516A1 (fr)
AU (1) AU3298800A (fr)
FR (1) FR2791142B1 (fr)
WO (1) WO2000055622A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2101177A1 (fr) * 2008-03-10 2009-09-16 Universite Joseph Fourier Utilisation d'un peptide synthétique dérivé de la protéine zébra pour le diagnostic in vitro de la réactivation du virus d'Epstein-Barr (EBV)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474769A (en) * 1991-03-08 1995-12-12 Sterling Winthrop Inc. Treatment of microbial infection by monocyte stimulation with interleukin-7
US5112607A (en) * 1991-06-05 1992-05-12 The United States Of America As Represented By The Secretary Of The Army Potentiation of immunotoxin action by Brefeldin A
US5254342A (en) * 1991-09-30 1993-10-19 University Of Southern California Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
WO1994006470A1 (fr) * 1992-09-15 1994-03-31 Johnson & Johnson Peptides immunoreactifs issus du virus d'epstein-barr
WO1996020723A1 (fr) * 1994-12-30 1996-07-11 Brigham & Women's Hospital Regulation de signaux induits par traf
FR2728904B1 (fr) * 1995-01-04 1997-03-14 Pasteur Institut Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif

Also Published As

Publication number Publication date
EP1163516A1 (fr) 2001-12-19
AU3298800A (en) 2000-10-04
WO2000055622A1 (fr) 2000-09-21
FR2791142A1 (fr) 2000-09-22

Similar Documents

Publication Publication Date Title
FI972945A (fi) Antigeenien antamiseen soveltuvia koostumuksia
MX158900A (es) Mejoras a composicion de champu para lavar la piel
MX9101127A (es) Composiciones de liberacion sostenidas para tratar enfermedad periodontal
NO901489D0 (no) Anordning for aa forbinde to kanter.
ITMI911392A1 (it) Meccanismo per compiere traiettorie prefissate assimilabili ad ellittiche
FR2737971B1 (fr) Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
IS5333A (is) Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku
IT1223654B (it) Dispositivo per l'applicazione all'estremita tagliata di un foglio per imbiallacciatura
FR2791142B1 (fr) Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa
FR2689011B1 (fr) Preparation phytotherapique cosmetique pour les levres.
IT1244638B (it) Dispositivo per eliminare formazione di peluria.
FR2746495B1 (fr) Tete militaire tandem pour l'attaque de cibles actives
FR2722649B1 (fr) Machine pour gaver les palmipedes au mais entier
FR2623359B1 (fr) Coutre reversible pour soc de charrue
FI960152A (fi) Laipio laivan kannen sulkemiseksi
BR9604898A (pt) Bomba para transportar uma polpa úmida
IT8221386V0 (it) Dispositivo associabile al corpo di una tazza igienica per consentire a quest'ultima di fungere da bidet.
IT1274542B (it) Dispositivo per impostare la priorita' di una presa elettrica
ES531546A0 (es) Una instalacion para facilitar el subsiguiente descortezado de troncos por friccion
ITMI930463A1 (it) Macchina per conformare la parte posteriore delle scarpe
IT1114312B (it) Dispositivo per impedire la formazione di gernggli parassiti lungo il fusto di una vite
ITBO950604A1 (it) Dispositivo per calzature, utilizzabile in particolare per prevenire la formazione di cariche elettrostatiche
KR970012183U (ko) 원심력에 변형되는 공
BR9501482A (pt) Bomba para tomar mate
ES1002255Y (es) Dispositivo para aumentar la altura de una bandeja-contenedor

Legal Events

Date Code Title Description
ST Notification of lapse